ES397573A1 - Biologically active imidazoles - Google Patents

Biologically active imidazoles

Info

Publication number
ES397573A1
ES397573A1 ES397573A ES397573A ES397573A1 ES 397573 A1 ES397573 A1 ES 397573A1 ES 397573 A ES397573 A ES 397573A ES 397573 A ES397573 A ES 397573A ES 397573 A1 ES397573 A1 ES 397573A1
Authority
ES
Spain
Prior art keywords
group
optionally substituted
groups
hydroxyl
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES397573A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of ES397573A1 publication Critical patent/ES397573A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/52—Nitrogen atoms not forming part of a nitro radical with hetero atoms directly attached to said nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A process for the preparation of new substituted imidazoles of general formula (VI) ** formula ** or a tautomeric or structural isomer thereof as defined above, where R1 is a carbocyclic or heterocyclic aromatic group, optionally substituted with one or more atoms optionally substituted halogen, hydroxyl, amino, thiol, sulfonic, or carboxylic groups or cyano, nitro, acyl, alkyl, aryl, or haloalkyl groups; R2 is an amino or hydroxyl group or an alkoxy, aryloxy or aralkoxy group optionally substituted with one or more halogen atoms or optionally substituted hydroxyl or tertiary amino groups, R4 is a hydrogen atom or a methyl group, R3 is an N = group N-NR5R6, where R5 is a beta-halogenated methyl or ethyl group and R6 is a hydrogen atom or a hydrocarbon group optionally substituted with a halogen atom or an optionally substituted tertiary amino or hydroxyl group and addition salts with acids, solvates or addition salts with solvated acids thereof, the process of which comprises the step of reacting the compound of the general formula ** formula ** where R''4 is a negative casing or a methyl group, with a compound of the general formula HNR5R6, whereupon optionally, if desired, replacing or modifying groups R1, R2 and/or R4 to provide other groups, R1, R2 and/or R4 by known method. (Machine-translation by Google Translate, not legally binding)
ES397573A 1970-12-09 1971-12-01 Biologically active imidazoles Expired ES397573A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5838570A GB1373346A (en) 1970-12-09 1970-12-09 Biologically active imidazoles

Publications (1)

Publication Number Publication Date
ES397573A1 true ES397573A1 (en) 1975-10-01

Family

ID=10481482

Family Applications (1)

Application Number Title Priority Date Filing Date
ES397573A Expired ES397573A1 (en) 1970-12-09 1971-12-01 Biologically active imidazoles

Country Status (13)

Country Link
AT (1) AT310740B (en)
BE (1) BE776422A (en)
CA (1) CA979428A (en)
DE (1) DE2161209A1 (en)
ES (1) ES397573A1 (en)
FR (1) FR2117939B1 (en)
GB (1) GB1373346A (en)
HU (1) HU163484B (en)
IE (1) IE35817B1 (en)
IL (1) IL38174A0 (en)
NL (1) NL7116331A (en)
SE (1) SE7412430L (en)
ZA (1) ZA717873B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019113227A1 (en) * 2017-12-06 2019-06-13 Yale University Prodrugs activated by reduction in the cytosol

Also Published As

Publication number Publication date
AT310740B (en) 1973-10-10
ZA717873B (en) 1972-08-30
IL38174A0 (en) 1972-01-27
SE7412430L (en) 1974-10-02
HU163484B (en) 1973-09-27
GB1373346A (en) 1974-11-13
AU3658871A (en) 1973-06-14
BE776422A (en) 1972-06-08
DE2161209A1 (en) 1972-06-22
IE35817L (en) 1972-06-09
FR2117939A1 (en) 1972-07-28
FR2117939B1 (en) 1975-06-13
NL7116331A (en) 1972-06-13
CA979428A (en) 1975-12-09
IE35817B1 (en) 1976-05-26

Similar Documents

Publication Publication Date Title
ES393496A1 (en) Cerivatives of 2-pyrrolidinone
SE7712630L (en) PROCEDURE FOR THE PREPARATION OF O-ALKYLATED HYDROXYLAMINES
ES462422A1 (en) Sulfonylglycolic anilide fungicides
SE7600954L (en) TETRAHYDROISOKINOLINE DERIVATIVES AND PROCEDURES FOR THE MANUFACTURE
ES410190A1 (en) Novel metallized heterocyclic derivatives
ES404744A1 (en) Cephalosporin derivatives
SE7612685L (en) PROCEDURE FOR PREPARING NEW IMIDAZOLE COMPOUNDS
ES395766A1 (en) Procedure for the obtaining of derivatives of hidantoin. (Machine-translation by Google Translate, not legally binding)
ES410313A2 (en) 3,4-dihydro-6,7-substituted-2,2,3-lower alkyl-4-oxo-(2h)-quinazolecarboxylic acid derivatives useful as analgesic and tranquilizer agents
ES328052A1 (en) Procedure for the preparation of thiophosphates with antiparastic effect. (Machine-translation by Google Translate, not legally binding)
ES451292A1 (en) A procedure for the preparation of tienotiacin derivatives. (Machine-translation by Google Translate, not legally binding)
ES400414A1 (en) Procedure for the preparation of N-substituted piperidine derivatives and their use as stabilizers. (Machine-translation by Google Translate, not legally binding)
ES389161A1 (en) Formamidine derivatives and the composition containing same
ES420766A1 (en) Alpha-pyrone derivatives and the preparation and uses thereof
ES437041A1 (en) A procedure for preparing 1-ftalazone derivatives. (Machine-translation by Google Translate, not legally binding)
ES398973A1 (en) PROCEDURE FOR OBTAINING A DERIVATIVE OF RIFAMICI-NA SV.
ES425868A1 (en) Preparation of carbamates
ES391118A1 (en) Novel glucuronic acid derivatives and process for the preparation thereof
ES432535A1 (en) A procedure for the preparation of benzodiazepinas-1,4. (Machine-translation by Google Translate, not legally binding)
ES424500A1 (en) A PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF 1-AMINO (SUBSTITUTE) -2-OXI) -2-PROPANOL.
ES392665A1 (en) Novel process for preparing i-substituted benzodiazepine derivatives
ES427387A1 (en) A PROCEDURE FOR THE PREPARATION OF DYES.
GB1120082A (en) Improvements in or relating to acetaldehyde diacylates and the manufacture thereof
ES439939A1 (en) Procedure for the preparation of new derivatives of isoxazolone. (Machine-translation by Google Translate, not legally binding)
ES362824A1 (en) Procedure for obtaining antiulcerosous compounds. (Machine-translation by Google Translate, not legally binding)